These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 9347001
1. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Wessel DL, Adatia I, Van Marter LJ, Thompson JE, Kane JW, Stark AR, Kourembanas S. Pediatrics; 1997 Nov; 100(5):E7. PubMed ID: 9347001 [Abstract] [Full Text] [Related]
8. Nitric oxide for respiratory failure in infants born at or near term. Barrington KJ, Finer N, Pennaforte T, Altit G. Cochrane Database Syst Rev; 2017 Jan 05; 1(1):CD000399. PubMed ID: 28056166 [Abstract] [Full Text] [Related]
9. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. J Pediatr; 1993 Jul 05; 123(1):103-8. PubMed ID: 8320602 [Abstract] [Full Text] [Related]
10. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Mercier JC, Lacaze T, Storme L, Rozé JC, Dinh-Xuan AT, Dehan M. Eur J Pediatr; 1998 Sep 05; 157(9):747-52. PubMed ID: 9776535 [Abstract] [Full Text] [Related]
11. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD. Crit Care Med; 1997 Feb 05; 25(2):352-9. PubMed ID: 9034276 [Abstract] [Full Text] [Related]
13. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Pediatrics; 2006 Apr 05; 117(4):1077-83. PubMed ID: 16585301 [Abstract] [Full Text] [Related]
15. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience. Gupta A, Rastogi S, Sahni R, Bhutada A, Bateman D, Rastogi D, Smerling A, Wung JT. J Perinatol; 2002 Sep 05; 22(6):435-41. PubMed ID: 12168118 [Abstract] [Full Text] [Related]
17. Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy. Fakioglu H, Totapally BR, Torbati D, Raszynski A, Sussmane JB, Wolfsdorf J. J Crit Care; 2005 Sep 05; 20(3):288-93. PubMed ID: 16253800 [Abstract] [Full Text] [Related]
18. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP. Pediatrics; 2000 Dec 05; 106(6):1339-43. PubMed ID: 11099586 [Abstract] [Full Text] [Related]
19. Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn. Muller W, Kachel W, Lasch P, Varnholt V, Konig SA. Intensive Care Med; 1996 Jan 05; 22(1):71-6. PubMed ID: 8857442 [Abstract] [Full Text] [Related]
20. International treatment outcomes of neonates on extracorporeal membrane oxygenation (ECMO) with persistent pulmonary hypertension of the newborn (PPHN): a systematic review. Alhumaid S, Alnaim AA, Al Ghamdi MA, Alahmari AA, Alabdulqader M, Al HajjiMohammed SM, Alalwan QM, Al Dossary N, Alghazal HA, Al Hassan MH, Almaani KM, Alhassan FH, Almuhanna MS, Alshakhes AS, BuMozah AS, Al-Alawi AS, Almousa FM, Alalawi HS, Al Matared SM, Alanazi FA, Aldera AH, AlBesher MA, Almuhaisen RH, Busubaih JS, Alyasin AH, Al Majhad AA, Al Ithan IA, Alzuwaid AS, Albaqshi MA, Alhmeed N, Albaqshi YA, Al Alawi Z. J Cardiothorac Surg; 2024 Aug 24; 19(1):493. PubMed ID: 39182148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]